Here’s the somewhat surprising stock that will soon join the S&P 500

UBS lowers 2026 S&P 500 target on Middle East conflict risks

OVL: Your Chance To Outperform The S&P While Collecting A 10% Yield

New to The Street Signs Medicus Pharma Ltd. (NASDAQ:MDCX) to Transformational 12-Part National Media Series Highlighting SkinJect(TM) and Teverelix(R) Platforms

Fiserv Western Alliance Deal Highlights Clover Growth Potential And Valuation Gap

S&P 500 Slumps in Worst Day Since War Began